Medicine
Mercaptopurine 20 mg/mL oral suspension
Mercaptopurine 20 mg/mL oral suspension is a generic prescription medicine for oral use, made by 2 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store MERCAPTOPURINE between 59ºF to 77ºF (15ºC to 25ºC). Store in a dry place.
Key facts
- Active ingredient (INN)
- Mercaptopurine
- Brand
- Sold under the generic name
- Strength
- 20 mg/mL
- Dosage form
- Oral suspension
- Route
- Oral
- Packs
- 1 bottle and 1 more
- Manufacturers
- Hikma PharmaceuticalsNova Laboratories
- Origin register
- US FDA, United States
- Storage
- Store MERCAPTOPURINE between 59ºF to 77ºF (15ºC to 25ºC). Store in a dry place.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L01BB02 Mercaptopurine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 28 April 2014
- Identifiers
- RxCUI 1536484, 1536490DailyMed set ID 9c6fc66b-522f-499d-961a-cde6ca0ec2e5, 0a366cf3-91f0-4aa4-8f34-a7a27cad8f15, 9fd27952-7787-47d9-b6cf-7af2dc38217b +1NDC 62484-1020, 0054-0879, 62484-0020 +1Application NDA205919, ANDA216418
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 bottle, glass in 1 carton / 100 mL in 1 bottle, glass | 0054-0879-49 | Hikma Pharmaceuticals | 16 June 2025 |
| 1 bottle, glass in 1 carton / 100 mL in 1 bottle, glass | 0054-4582-49 | Hikma Pharmaceuticals | 26 February 2025 |
| 1 bottle in 1 carton / 100 mL in 1 bottle | 62484-0020-2 | Nova Laboratories | 28 April 2014 |
| 1 bottle in 1 carton / 100 mL in 1 bottle | 62484-1020-4 | Nova Laboratories | 8 September 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Mercaptopurine
Clinical summary
Mercaptopurine is a nucleoside metabolic inhibitor indicated for treatment of adult and pediatric patients with acute lymphoblastic leukemia (ALL) as part of a combination chemotherapy maintenance regimen. It is available as oral suspension and tablets. MedsAcross supplies Mercaptopurine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MercaptopurineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Mercaptopurine prescribing information (Florida Pharmaceutical Products) · U.S. National Library of Medicine, DailyMed
- Xaluprine (previously Mercaptopurine Nova Laboratories): European public assessment report (EPAR) · European Medicines Agency
Need Mercaptopurine 20 mg/mL oral suspension for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.